approval
saveABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval
community read0 votes
Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalARIPIPRAZOLE — FDA approvalFeb 18, 2026 · 275d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJan 28, 2026 · 296d ago
- approvalARIPIPRAZOLE — FDA approvalOct 22, 2025 · 394d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalMar 28, 2025 · 602d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJan 22, 2025 · 667d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalFeb 5, 2020 · 2480d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJul 27, 2017 · 3403d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalFeb 23, 2017 · 3557d ago
comments(0)
5-min edit window · permanent after that